$21.37
Price
$2.2B
Market Cap
—
P/E Ratio
7.8
Forward P/E
$-2.83
EPS (TTM)
—
Dividend Yield
$851M
Cash
$1.3B
Total Debt
105M
Shares Out
$10.42
$120.05
52-Week Range
Institutional Ownership of SAREPTA THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for SAREPTA THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for SAREPTA THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $294K
0
Buys
1
Sells
-294K
Net
4
Grants
Largest
$294K
Estepan
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 16, 2025 | Ian Michael Estepan | Chief Operating Officer | SELL | 13.2K | $22.31 | $294K |
| Dec 07, 2025 | Douglas S Ingram | Chief Executive Officer | GRANT | 50.0K | — | — |
| Dec 07, 2025 | Douglas S Ingram | Chief Executive Officer | GRANT | 73.0K | — | — |
| Dec 07, 2025 | Douglas S Ingram | Chief Executive Officer | GRANT | 96.5K | — | — |
| Dec 07, 2025 | Douglas S Ingram | Chief Executive Officer | GRANT | 269.5K | — | — |